ClinicalTrials.Veeva

Menu

Evaluation of Voice in Behcet's

M

Minia University

Status

Not yet enrolling

Conditions

Behcet Disease

Treatments

Other: 1-Laryngyscopic examination 2-Acoustic analysis

Study type

Observational

Funder types

Other

Identifiers

NCT06836817
voice in Behcet's Disease

Details and patient eligibility

About

Behçet's disease (BD) is a systemic inflammatory condition of unknown origin with no definite aetiopathogenetic pathways accepted worldwide. To date, only a few studies have investigated laryngeal involvement in BD and data about this are scarce. For these reasons, the present study focuses on verifying the occurrence of vocal cord involvement in patients with BD, identifying potential correlations with specific demographic, clinical, and therapeutic characteristics.

Full description

Behçet's disease (BD) is a systemic inflammatory condition of unknown origin with no definite aetiopathogenetic pathways accepted worldwide. BD owes its name to the Turkish dermatologist Hulusi Behçet, whom published in 1937 two cases of oral aphthous, genital ulcers, and recurrent uveitis with hypopion, known as triple-symptom complex. In addition to these, other clinical features encompass musculoskeletal, gastrointestinal, renal, pulmonary, cardiovascular, and cutaneous manifestations including erythema nodosum and pseudofolliculitis.To date, only a few studies have investigated laryngeal involvement in BD and data about this are scarce. For these reasons, the present study focuses on verifying the occurrence of vocal cord involvement in patients with BD, identifying potential correlations with specific demographic, clinical, and therapeutic characteristics.The study will include 60 volunteers. They will divided into 2 groups. Group I will comprise of the 30 patients with Behçet's disease (BD), and Group II will comprise of 30 controls.The inclusion criteria for selection of Group I participants will based on the criteria of the International Study Group which was proposed in 1990. The inclusion criteria for Group II will not have a Behcet's Disease.Methods

  1. History taking.

  2. voice sample by recording (in sustained vowel |a| )

  3. Auditory Perceptual Assessment (APA): (Kotby et al., 1986)

  4. Laryngyscopic examination:

    Patients will taken to a room with a tower on which the 8.5 mm 70 rigid laryngoscope (KARL STORZ - endoscope) (Tele pack X LED).

  5. Acoustic analysis: The voice sample will be subjected to computerized acoustic analysis using Multidimensional voice program software(MDVP).

Enrollment

60 estimated patients

Sex

All

Ages

10+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The inclusion criteria for selection of Group I participants will based on the criteria of the International Study Group which was proposed in 1990. The inclusion criteria for Group II will not have a Behcet's Disease.

Exclusion criteria

  • other autoimmune diseases.

Trial design

60 participants in 2 patient groups

Group I
Description:
Group I will comprise of the 30 patients with Behçet's disease (BD).
Treatment:
Other: 1-Laryngyscopic examination 2-Acoustic analysis
Group II
Description:
Group II will comprise of 30 controls.
Treatment:
Other: 1-Laryngyscopic examination 2-Acoustic analysis

Trial contacts and locations

0

Loading...

Central trial contact

Wafaa Helmy Abd El-hakeem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems